carvedilol and 4-hydroxy-2-nonenal

carvedilol has been researched along with 4-hydroxy-2-nonenal in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gabriels, M; Vamecq, J; Van den Branden, C; Vanden Houte, K; Verbeelen, D	1
Emori, T; Kakishita, M; Kusano, K; Matsubara, H; Miyaji, K; Morita, H; Nagase, S; Nakamura, K; Nakamura, Y; Ohe, T; Ohta, K; Saito, H; Toyokuni, S; Yamamoto, M	1
Chen, P; Ge, LS; Guan, XQ; Li, YC; Lin, JF; Tang, JF; Yang, PL	1

Trials

1 trial(s) available for carvedilol and 4-hydroxy-2-nonenal

Article	Year
Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation, 2002, Jun-18, Volume: 105, Issue:24 Topics: Adrenergic beta-Antagonists; Aldehydes; Antioxidants; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart; Hemodynamics; Humans; Immunohistochemistry; Lipid Peroxidation; Male; Middle Aged; Myocardium; Oxidative Stress; Propanolamines; Proteins; Vasodilator Agents	2002

Article

Year

Carvedilol decreases elevated oxidative stress in human failing myocardium.

Circulation, 2002, Jun-18, Volume: 105, Issue:24

Topics: Adrenergic beta-Antagonists; Aldehydes; Antioxidants; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Female; Heart; Hemodynamics; Humans; Immunohistochemistry; Lipid Peroxidation; Male; Middle Aged; Myocardium; Oxidative Stress; Propanolamines; Proteins; Vasodilator Agents

2002

Other Studies

2 other study(ies) available for carvedilol and 4-hydroxy-2-nonenal

Article	Year
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol. Nephron, 1997, Volume: 77, Issue:3 Topics: Adrenergic beta-Antagonists; Aldehydes; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Free Radical Scavengers; Glomerulosclerosis, Focal Segmental; Hydrogen Peroxide; Kidney Cortex; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Nephrectomy; Propanolamines; Propranolol; Rats; Rats, Wistar	1997
Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction. European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3 Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography; Enterovirus; Glutathione Peroxidase; Heart; Hemodynamics; Male; Malondialdehyde; Metoprolol; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Organ Size; Oxidative Stress; Propanolamines; Superoxide Dismutase; Survival Rate; Time Factors; Viral Load	2010

Article

Year

Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.

Nephron, 1997, Volume: 77, Issue:3

Topics: Adrenergic beta-Antagonists; Aldehydes; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilol; Free Radical Scavengers; Glomerulosclerosis, Focal Segmental; Hydrogen Peroxide; Kidney Cortex; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Nephrectomy; Propanolamines; Propranolol; Rats; Rats, Wistar

1997

Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.

European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography; Enterovirus; Glutathione Peroxidase; Heart; Hemodynamics; Male; Malondialdehyde; Metoprolol; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Organ Size; Oxidative Stress; Propanolamines; Superoxide Dismutase; Survival Rate; Time Factors; Viral Load

2010